Is SOLS a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Low-GWP refrigerant transition, with revenue (ttm) at ~$4.1B; Q2 2026 ~$1.15B, up ~11% YoY. The bear case rests on the planned $14.5 billion Element Solutions acquisition adds substantial debt through a $4.7 billion bridge facility, raising integration and balance-sheet risk, and it is not expected to close until the first half of 2027 subject to regulatory approvals. Analysts covering it are spread from $65.00 to $86.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The planned $14.5 billion Element Solutions acquisition adds substantial debt through a $4.7 billion bridge facility, raising integration and balance-sheet risk, and it is not expected to close until the first half of 2027 subject to regulatory approvals. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $65.00, +9.7% from the $59.25 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Low-GWP refrigerant transition. Solstice is a leading maker of low-global-warming-potential (LGWP) refrigerants and blowing agents as regulations phase down older HFCs worldwide. The most optimistic analyst target on SOLS is $86.00, +45.1% from the $59.25 price. That figure is only reachable if this thesis works close to its best case.

The planned $14.5 billion Element Solutions acquisition adds substantial debt through a $4.7 billion bridge facility, raising integration and balance-sheet risk, and it is not expected to close until the first half of 2027 subject to regulatory approvals. The stock trades at a high trailing price-to-earnings multiple (about 46x in October 2026, against roughly 18x forward), so any earnings disappointment could weigh heavily, and trailing free cash flow was slightly negative. Legacy liabilities matter too: the company has reached only an agreement in principle to settle litigation over the Metropolis Works uranium conversion plant, and that deal still needs formal documentation and approvals. Refrigerant markets are cyclical and exposed to feedstock costs, regulatory shifts and competition from larger chemical players. The electronics and semiconductor end markets are also cyclical, and as a recently spun-off company SOLS has a short standalone trading history, with a 52-week range of about $40 to $91. The most pessimistic published target is $65.00, +9.7% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Solstice Advanced Materials is a Morris Plains, New Jersey specialty-chemicals company that began trading on Nasdaq on October 30, 2025 after being spun off from Honeywell.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Low-GWP refrigerant transition) stalling in the reported numbers rather than in the narrative, the risk above (the planned $14.5 billion Element Solutions acquisition adds substantial debt through a $4.7 billion bridge facility, raising integration and balance-sheet risk, and it is not expected to close until the first half of 2027 subject to regulatory approvals) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

It makes specialty materials, chiefly low-global-warming-potential refrigerants, blowing agents, solvents and aerosols in its RAS segment, plus electronic materials, industrial fibers and life-sciences chemicals in its ESM segment. Customers span HVAC/R, semiconductors, defense, pharmaceutical and construction markets.

Solstice Advanced Materials was spun off from Honeywell and began trading independently on Nasdaq on October 30, 2025. It houses Honeywell's former specialty-materials businesses, including the Solstice-branded refrigerant line, as a standalone public company based in New Jersey.

Yes. For full-year 2025 the company reported net sales of about $3.9 billion, net income near $237 million and adjusted standalone EBITDA of roughly $957 million at a margin around 24.6%. Trailing-twelve-month net income was about $210 million as of mid-2026, after a second quarter in which net income reached roughly $119 million.